Latest Breaking News On - Pieter sonneveld - Page 1 : comparemela.com

Quadruple Therapies Including Immunotherapy Agents Show Benefit in Multiple Myeloma

Quadruple Therapies Including Immunotherapy Agents Show Benefit in Multiple Myeloma
pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.

United statesPieter sonneveldC ola landgrenJanssen biotech incNational cancer instituteAmerican society of clinical oncology annual meetingClinical oncology annualJanssen biotechHum vaccinNew england journal

Subcutaneous Daratumumab Plus VRd Significantly Improves PFS, Increases Depth of Response in Patients With Newly Diagnosed Multiple Myeloma

Data support the quadruplet regimen as a new standard of care for transplant-eligible patients.

San diegoUnited statesZuid hollandVrdd vrdPieter sonneveldAmerican society of hematology annual meeting expositionErasmus medical center cancer institute in rotterdamErasmus university rotterdamJanssen biotechAmerican societyHematology annual meetingErasmus medical center cancer institute

Practice-changing study on bone marrow cancer therapy

Practice-changing study on bone marrow cancer therapy
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Michele cavoMeral beksacAurore perrotCyrille hulinMeletiosa dimopoulosHermann einseleMario boccadoroSilvia mangiacavalliXavier leleuPieter sonneveldEuropean myeloma networkJanssen researchUniversity hospitalNational tumour centreMedical clinicEuropean myeloma

Daratumumab-based regimen a future standard for certain patients with multiple myeloma

Daratumumab-based regimen a future standard for certain patients with multiple myeloma
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesPieter sonneveldMansir shahInternational myeloma working groupJanssen pharmaceuticalsErasmus mc cancer instituteErasmus university of rotterdamRutgers cancer institute of new jerseyRwjbarnabas healthEuropean myeloma networkBristol myers squibbThenew england journalErasmus universityCancer institute

J&J: new positive data in multiple myeloma -December 13, 2023 at 10:00 am EST

Johnson & Johnson has announced that initial data from a Phase 3 study demonstrate significant clinical improvement in newly diagnosed multiple myeloma patients eligible for transplantation with a.

Darzalex fasproPieter sonneveldProfessor of hematology at erasmus university rotterdamErasmus university